Previous Article | Next Article 
Journal of Clinical Microbiology, June 2000, p. 2407-2408, Vol. 38, No. 6
0095-1137/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
High Prevalence of TT Virus DNA in Human Saliva
and Semen
Tomoko
Inami,1,2
Nami
Konomi,1,2
Yasuyuki
Arakawa,2 and
Kenji
Abe1,*
Department of Pathology, National Institute
of Infectious Diseases,1 and Third
Department of Internal Medicine, Nihon University School of
Medicine,2 Tokyo, Japan
Received 1 October 1999/Returned for modification 11 February
2000/Accepted 15 March 2000
 |
ABSTRACT |
Using the PCR assay, we found a high prevalence of TT virus (TTV)
DNA in saliva and semen from patients who were seropositive for TTV.
This finding suggests that the presence of TTV in body fluids other
than serum may affect the routes of viral transmission.
 |
TEXT |
Recently, the genome from a novel
DNA virus, termed the TT virus (TTV), was isolated from the serum of
patients with posttransfusion non-A-G hepatitis by using
representational difference analysis (6, 8). TTV is an
unenveloped single-stranded DNA virus, with an isopycnic density of
1.31 to 1.32 g/ml in CsCl (8). The TTV genome has two
possible open reading frames, capable of encoding 770 and 202 amino
acids. Due to the genome structure and its banding in buoyant density
gradient centrifugation, TTV might be most closely related to
Circoviridae among the known animal virus families (3,
4, 10). The TTV sequence was detected in sera and liver tissues
from liver disease patients, suggesting that TTV might be responsible
for a part of acute and chronic liver disease of unknown etiology
(2, 8). On the other hand, it has been reported that TTV
infection does not induce significant liver damage (5).
Members of our group recently reported that TTV infection is widespread
in the general population worldwide and suggested that TTV may be a
common DNA virus in humans (1). This implies that the routes
of TTV transmission may differ from the routes of hepatitis B virus
(HBV), hepatitis C virus (HCV), and hepatitis G virus (HGV)
transmission. The presence of virus in body fluids other than serum,
such as saliva and semen, may affect the routes of viral transmission.
Accordingly, we analyzed whether TTV is present in extravascular compartments.
Paired samples of serum, saliva, and semen were obtained from 10 drug
addicts (all males, ranging in age from 18 to 54 years), either
intravenous drug users or heroin smokers. Four of them were coinfected
with HCV, but no evidence of HBV, HGV, or human immunodeficiency virus
infections was obtained by PCR assays. Saliva and semen were collected
in sterile tubes and stored at
30°C until use. Informed consent was
obtained from the participants in this study. DNA was extracted from
100 µl of serum, saliva, and semen, respectively, using a nucleic
acid extraction kit (SepaGene RV-R; Sanko Junyaku Co., Ltd., Tokyo,
Japan). The semen was diluted to twice its original volume with
phosphate-buffered saline and used for DNA extraction. TTV DNA was
amplified by PCR as described previously (1). In brief, the
thermocycler was programmed first to preheat at 95°C for 10 min to
activate AmpliTaq Gold DNA polymerase (Perkin-Elmer, Norwalk,
Conn.), followed by 55 cycles consisting of 94°C for 20 s,
60°C for 20 s, and 72°C for 30 s using a Perkin-Elmer 9600 or 9700 thermal cycler. The sequences of the TTV-specific primers
were 5'-GCTACGTCACTAACCACGTG-3' (T801, sense primer;
nucleotides 6 to 25) and 5'-CTBCGGTGTGTAAACTCACC-3' (T935,
antisense primer; nucleotides 185 to 204; B = G, C, or T) as
designed by Takahashi et al. (9) in the 5' end region of the
TA278 isolate. The PCR products were detected by electrophoresis on 2%
agarose gels, stained with ethidium bromide, and photographed under UV
light. The sizes of the PCR products were estimated according to the migration pattern of a 50-bp DNA ladder (Pharmacia Biotech, Uppsala, Sweden). All PCR assays were performed in duplicate to confirm specificity. To characterize the nucleotide sequence of isolated TTVs,
amplicons were purified using a QIAquick gel extraction kit (Qiagen
Inc., Chatsworth, Calif.). The recovered PCR products were subjected to
direct sequencing from both directions using the ABI Prism dye
terminator cycle sequencing ready reaction kit (Perkin-Elmer).
Sequences of amplified DNA were determined by using a sequencer (ABI
model 373A; Applied Biosystems, Foster City, Calif.).
As a result, TTV DNA was detected in the serum of 10 (10 of 10 [100%]), the saliva of 7 (7 of 9 [78%]), and the semen of 6 (6 of
10 [60%]) individuals (Table 1). In
contrast, HCV RNA was detected in the saliva and semen of only one
(20%) of five patients who were seropositive for HCV RNA. Elevated
serum alanine aminotransferase was found in five patients coinfected
with HCV and TTV but not in the remaining patients infected only with
TTV. To verify that the products amplified by PCR were of TTV origin,
sequence analyses were performed in three cases. The results revealed
that although the nucleotide sequences of TTV DNA from serum, saliva,
and semen had sequence variations among them, all had a high level of
similarity to the TA278 isolate, which is the prototype of TTV
(Fig. 1).
View this table:
[in this window]
[in a new window]
|
TABLE 1.
Detection of TTV DNA in serum and body fluids from 10 male drug addicts and comparison with HCV RNA detection
|
|

View larger version (14K):
[in this window]
[in a new window]
|
FIG. 1.
Comparison of nucleotide sequences of TTV recovered from
paired samples of serum, saliva, and semen from three individuals
(cases 4, 6, and 9).
|
|
Our results indicate that TTV DNA, besides being present in blood, can
also be found frequently in saliva and semen. It was reported
previously that TTV viremia is widespread in the general population
worldwide, since the prevalence among patients, including healthy
populations, was found to be more than 70% (1). Such an
extremely high prevalence of TTV infection in the general population suggests that TTV may be transmissible not only through blood but also
by a nonparenteral route. Indeed, Okamoto et al. reported that TTV was
excreted in the feces, thereby suggesting that TTV is transmitted not
only parenterally but also nonparenterally by a fecal-oral route
(7). In addition to the feces, TTV would be transmitted by
saliva and semen. The high degree of similarity between the paired
samples of serum-, saliva-, and semen-derived TTV sequences suggests
that the virus detected in saliva and semen originated from the same
source as the virus found in serum. Sequence analysis of TTV DNA from
serum, saliva, and semen showed little variation among the samples
examined. It is known that despite TTV being a DNA virus, the TTV
sequence has a wide range of divergence (1, 4, 8).
In conclusion, a high prevalence of TTV DNA in saliva and semen from
patients infected with TTV was found by PCR assay. This finding
suggests that body fluids other than serum may be significant vehicles
for the nonparenteral transmission of TTV, although the infectivity of
TTV DNA-positive body fluids remains to be demonstrated.
 |
ACKNOWLEDGMENTS |
We thank Takeshi Kurata for his continuous encouragement during
this study and Hideo Naito and Naoto Aiba for their kind cooperation.
This study was supported in part by Grants-in-Aid for Science Research
of the Ministry of Education, Science and Culture of Japan and the
Ministry of Health and Welfare of Japan.
 |
FOOTNOTES |
*
Corresponding author. Mailing address: Department of
Pathology, National Institute of Infectious Diseases, Toyama 1-23-1, Shinjuku-ku, Tokyo 162-8640, Japan. Phone: (81) 3-5285-1111, ext. 2624. Fax: (81) 3-5285-1189 or (81) 3-5285-1150. E-mail:
kenjiabe{at}nih.go.jp.
 |
REFERENCES |
| 1.
|
Abe, K.,
T. Inami,
K. Asano,
C. Miyoshi,
N. Masaki,
S. Hayashi,
K.-I. Ishikawa,
Y. Takebe,
K. M. Win,
A. R. El-Zayadi,
K.-H. Han, and D. Y. Zhang.
1999.
TT virus infection is widespread in the general populations from different geographic regions.
J. Clin. Microbiol.
37:2703-2705[Abstract/Free Full Text].
|
| 2.
|
Charlton, M.,
P. Adjei,
J. Poterucha,
N. Zein,
B. Moore,
T. Therneau,
R. Krom, and R. Wiesner.
1998.
TT-virus infection in North American blood donors, patients with fulminant hepatic failure, and cryptogenic cirrhosis.
Hepatology
28:839-842[CrossRef][Medline].
|
| 3.
|
Miyata, H.,
H. Tsunoda,
A. Kazi,
A. Yamada,
M. A. Khan,
J. Murakami,
T. Kamahora,
K. Shiraki, and S. Hino.
1999.
Identification of a novel GC-rich 113-nucleotide region to complete the circular, single-stranded DNA genome of TT virus, the first human circovirus.
J. Virol.
73:3582-3586[Abstract/Free Full Text].
|
| 4.
|
Mushahwar, I. K.,
J. C. Erker,
A. S. Muerhoff,
T. P. Leary,
J. N. Simons,
L. G. Birkenmeyer,
M. L. Chalmers,
T. J. Pilot-Matias, and S. M. Dexai.
1999.
Molecular and biophysical characterization of TT virus: evidence for a new virus family infecting humans.
Proc. Natl. Acad. Sci. USA
96:3177-3182[Abstract/Free Full Text].
|
| 5.
|
Naoumov, N. V.,
E. P. Petrova,
M. G. Thomas, and R. Williams.
1998.
Presence of a new described human DNA virus (TTV) in patients with liver disease.
Lancet
352:195-197[CrossRef][Medline].
|
| 6.
|
Nishizawa, T.,
H. Okamoto,
K. Konishi,
H. Yoshizawa,
Y. Miyakawa, and M. Mayumi.
1997.
A novel DNA virus (TTV) associated with elevated transaminase levels in posttransfusion hepatitis of unknown etiology.
Biochem. Biophys. Res. Commun.
241:92-97[CrossRef][Medline].
|
| 7.
|
Okamoto, H.,
Y. Akahane,
M. Ukita,
M. Fukuda,
F. Tsuda,
Y. Miyakawa, and M. Mayumi.
1998.
Fecal excretion of a nonenveloped DNA virus (TTV) associated with posttransfusion non-A-G hepatitis.
J. Med. Virol.
56:128-132[CrossRef][Medline].
|
| 8.
|
Okamoto, H.,
T. Nishizawa,
N. Kato,
M. Ukita,
H. Ikeda,
H. Iizuka,
Y. Miyakawa, and M. Mayumi.
1998.
Molecular cloning and characterization of a novel DNA virus (TTV) associated with posttransfusion hepatitis of unknown etiology.
Hepatol. Res.
10:1-16.
|
| 9.
|
Takahashi, K.,
H. Hoshino,
Y. Ohta,
N. Yoshida, and S. Mishiro.
1998.
Very high prevalence of TT virus (TTV) infection in general population of Japan revealed by a new set of PCR primers.
Hepatol. Res.
12:233-239.
|
| 10.
|
Takahashi, K.,
Y. Ohta, and S. Mishiro.
1998.
Partial ~2.4kb sequence of TT virus genome from eight Japanese isolates: diagnostic and phylogenetic implications.
Hepatol. Res.
12:111-120[CrossRef].
|
Journal of Clinical Microbiology, June 2000, p. 2407-2408, Vol. 38, No. 6
0095-1137/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Azzi, A., De Santis, R., Morfini, M., Zakrzewska, K., Musso, R., Santagostino, E., Castaman, G.
(2001). TT virus contaminates first-generation recombinant factor VIII concentrates. Blood
98: 2571-2573
[Abstract]
[Full Text]
-
Fornai, C., Maggi, F., Vatteroni, M. L., Pistello, M., Bendinelli, M.
(2001). High Prevalence of TT Virus (TTV) and TTV-Like Minivirus in Cervical Swabs. J. Clin. Microbiol.
39: 2022-2024
[Abstract]
[Full Text]
-
Bendinelli, M., Pistello, M., Maggi, F., Fornai, C., Freer, G., Vatteroni, M. L.
(2001). Molecular Properties, Biology, and Clinical Implications of TT Virus, a Recently Identified Widespread Infectious Agent of Humans. Clin. Microbiol. Rev.
14: 98-113
[Abstract]
[Full Text]